1、Why ESG Matters for Medtech in the Asia-Pacific RegionNearly 70%of medtech customers surveyed expect ESG will become a core purchasing criteria.By Vikram Kapur,Kevin Chang,Miki Yu,Glenda Ya-Wen Teng,and Benish Aslam Why ESG Matters for Medtech in the Asia-Pacific1APACMed|Bain&Company,Inc.As a new er

2、a for the medtech industry in the Asia-Pacific region approaches,the integration of ESG considerations emerges not merely as a trend but as an imperative.The upcoming decade promises rapid advancements in medical technology,intertwined with an intensified focus on sustainability and ethical governan

3、ce.The industry can expect innovations catering to medical needs while priori-tizing environmental and social concerns.The ascent of digital health solutions,telemedicine,and AI-driven diagnostics will revolutionize patient care and reduce the carbon footprint by minimizing reliance on physical infr

4、astructure and transportation.Challenges are inevitable.Evolving regulatory landscapes,shifting consumer expectations,and the global economic milieu will present unforeseen obstacles.Yet within these challenges lie unparalleled opportunities.Medtech companies that wholeheartedly embrace ESG will pos

5、ition themselves as market leaders and vanguards of thought and innovation.These trailblazers will set industry benchmarks,influence policy frameworks,and command consumer trust.Collaboration remains paramount.Governments,industry stakeholders,investors,and consumers must work together to create an

6、ecosystem that champions innovation while upholding ESG tenets.Endeavors such as cross-border research collaborations,sustainability-centric investment portfolios,and consumer education campaigns can expedite the industrys trajectory toward a sustainable future.This report is a collaboration between